---
figid: PMC10458733__pharmaceutics-15-02149-g005
pmcid: PMC10458733
image_filename: PMC10458733__pharmaceutics-15-02149-g005.jpg
figure_link: /pmc/articles/PMC10458733/figure/F5/
number: Figure 5
figure_title: Effect of Br-MSCs and/or their derived EXOs on renal expression of mir-34a/SNHG-7/AMPK/ULK-1–AKT/mTOR
  signaling pathway (A–F).
caption: Effect of Br-MSCs and/or their derived EXOs on renal expression of mir-34a/SNHG-7/AMPK/ULK-1–AKT/mTOR
  signaling pathway (A–F). (A) Relative expression of mir-34a/U6 (% control), (B)
  relative expression of Lncr SNHG-7/Gapdh (% control), (C) relative expression of
  AMPK/Gapdh (% control), (D) relative expression of ULK-1/Gapdh (% control), (E)
  relative expression of mTOR/Gapdh (% control), and (F) relative expression of AKT-1/Gapdh
  (% control). Values are the mean of (n) 6–8 rats per group ± S.E.M. * p < 0.05,
  ** p < 0.01, *** p < 0.001, **** p < 0.0001
article_title: Breast Milk Mesenchymal Stem Cells and/or Derived Exosomes Mitigated
  Adenine-Induced Nephropathy via Modulating Renal Autophagy and Fibrotic Signaling
  Pathways and Their Epigenetic Regulations
citation: Tarek Khamis, et al. Pharmaceutics. 2023 Aug;15(8).
year: '2023'
pub_date: 2023-8-
epub_date: 2023-8-16
doi: 10.3390/pharmaceutics15082149
journal_title: Pharmaceutics
journa_nlm_ta: Pharmaceutics
publisher_name: MDPI
keywords:
- mesenchymal stem cells
- exosomes
- miRNA
- mRNA
- long-non-coding RNA
---
